The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Kailash Shantilal Choudhari
AKSHOPTFBR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
BSE has received a disclosure under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Dr. Kailash Shantilal Choudhari, a promoter of Aksh Optifibre Ltd. Filings under this regulation are typically made when a promoter or person acting in concert creates, releases, or invokes an encumbrance (such as a pledge) on the company's shares. The headline does not specify the exact nature of the encumbrance event, the number of shares involved, or the current shareholding details. Shareholders should refer to the full disclosure on the BSE portal to understand whether this represents a pledge creation, release, or invocation.
The filing is procedural and reflects a regulatory disclosure obligation by a promoter; the actual impact on share price or shareholder interests depends on whether the underlying event is a pledge creation, release, or invocation, which is not stated in the headline.